Documentation scienceplus.abes.fr version Bêta

À propos de : Enoxaparin had lower costs than unfractionated heparin for acute coronary syndrome        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Enoxaparin had lower costs than unfractionated heparin for acute coronary syndrome
has manifestation of work
Abstract
  • MarkDBCowperPABerkowitzSD. Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients. Results from the ESSENCE randomized trial. Circulation. 1998 May 5;97:1702-7.
article type
publisher identifier
  • ebmed3193
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata